CARLOS
MACAYA MIGUEL
Profesor emérito
Vicente
Mainar
Publicaciones en las que colabora con Vicente Mainar (9)
2019
-
Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial
Catheterization and Cardiovascular Interventions, Vol. 94, Núm. 7, pp. 917-925
2018
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991
2015
-
A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial
Journal of the American College of Cardiology, Vol. 66, Núm. 1, pp. 23-33
-
Erratum: A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: The RIBS IV randomized clinical trial (Journal of the American College of Cardiology (2015) 66 (23-33))
Journal of the American College of Cardiology
2014
-
A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)
Journal of the American College of Cardiology, Vol. 63, Núm. 14, pp. 1378-1386
2011
-
Primary percutaneous coronary intervention for ST-segment elevation acute myocardial infarction in nonagenarian patients: Results from a Spanish multicentre registry
EuroIntervention, Vol. 6, Núm. 9, pp. 1080-1084
2010
-
A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated by EveroLimus-Eluting Stent) trial
EuroIntervention, Vol. 6, Núm. 1, pp. 112-116
-
Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: The assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial
Circulation, Vol. 121, Núm. 10, pp. 1176-1187
2007
-
PexeLizumab for Acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: A randomized controlled trial
Journal of the American Medical Association, Vol. 297, Núm. 1, pp. 43-51